Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 27K
2: EX-10.1 Material Contract HTML 111K
6: R1 Cover HTML 47K
8: XML IDEA XML File -- Filing Summary XML 11K
11: XML XBRL Instance -- docu-20240313_htm XML 14K
7: EXCEL IDEA Workbook of Financial Report Info XLSX 8K
4: EX-101.LAB XBRL Labels -- docu-20240313_lab XML 64K
5: EX-101.PRE XBRL Presentations -- docu-20240313_pre XML 34K
3: EX-101.SCH XBRL Schema -- docu-20240313 XSD 10K
9: JSON XBRL Instance as JSON Data -- MetaLinks 12± 17K
10: ZIP XBRL Zipped Folder -- 0001261333-24-000032-xbrl Zip 32K
(Exact name of registrant as specified in its charter)
______________________________________
iDelaware
i91-2183967
(State
or Other Jurisdiction of Incorporation)
(I.R.S. Employer Identification Number)
i221 Main St.
iSuite
1550
iSan Francisco
iCalifornia
i94105
(Address
of Principal Executive Offices)
(Zip Code)
(i415) i489-4940
(Registrant's Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions (see General Instructions A.2. below):
i¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i¨
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i¨
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
iCommon Stock, par value $0.0001 per share
iDOCU
iThe
Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth companyi¨
If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.¨
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(e) Enhanced Severance Benefits
On
January 10, 2024, the Compensation and Leadership Development Committee of the Board of Directors (the “Committee”) of DocuSign, Inc. (the “Company”) approved the form of Amended and Restated Executive Severance and Change in Control Agreement (the “Restated Executive Severance Agreement”) to be entered into with certain of the Company’s executive officers, including Stephen Shute, President, Worldwide Field Operations (each a “Covered Officer”). The Restated Executive Severance Agreements were approved to coordinate and consolidate the prior amendments to the Executive Severance Agreements and to provide strong retention incentives by including certain limited enhanced benefits in the event of a Covered Officer’s termination without “Cause” from the date of execution through December
31, 2024.
The form Restated Executive Severance Agreement is described in the Company’s Form 8-K filed with the Securities and Exchange Commission on January 16, 2024, and is qualified in its entirety by reference to the full text of the form of Restated Executive Severance Agreement, which was filed as Exhibit 10.1 thereto.
On March 13, 2024, the Company and Mr. Shute entered into a second amendment and restatement of Mr. Shute’s Restated Executive
Severance Agreement (the “Shute Second Restatement”) to provide that Mr. Shute will be eligible for the enhanced benefits upon either a termination without “Cause” or a resignation for “Good Reason” at any time, which benefits were previously only available upon a termination without “Cause” through December 31, 2024. As a result of the Shute Second Restatement, upon either such termination, he will be eligible for 12 months (rather than six months) of COBRA coverage and 12 months (rather than six months) of vesting acceleration under his time-based equity awards. All other terms and conditions of Mr. Shute’s Restated Executive Severance Agreement remain unchanged.
The foregoing descriptions of the Shute Second Restatement is not complete and is qualified in its entirety by reference to the full text of the Shute
Second Restatement, which is filed as Exhibit 10.1 hereto.
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
